We analyzed a series of young (median age 5 52 years) nonsmoker lung cancer patients and their unaffected siblings as controls, using a genome-wide 620 901 single-nucleotide polymorphism (SNP) array analysis and a case-control DNA pooling approach. We identified 82 putatively associated SNPs that were retested by individual genotyping followed by use of the sib transmission disequilibrium test, pointing to 36 SNPs associated with lung cancer risk in the discordant sibs series. Analysis of these 36 SNPs in a polygenic model characterized by additive and interchangeable effects of rare alleles revealed a highly statistically significant dosage-dependent association between risk allele carrier status and proportion of cancer cases. Replication of the same 36 SNPs in a population-based series confirmed the association with lung cancer for three SNPs, suggesting that phenocopies and genetic heterogeneity can play a major role in the complex genetics of lung cancer risk in the general population.
Introduction
In addition to the major role of cigarette smoking, inherited predisposition of a complex nature appears to play a role in lung cancer risk. Segregation analyses in lung cancer families (1) and genetic linkage studies in mouse models (2) support the polygenic nature of inherited susceptibility to lung cancer (3) . However, there is currently no model that adequately explains the complex genetics of lung cancer predisposition and results from linkage and/or association studies are contrasting. For example, a single major genetic locus linked to lung cancer risk in pedigrees with multiple lung cancer members and mapping on chromosome 6q23-25 (4) has not been detected in genomewide association studies of population-based case-control series (5) (6) (7) (8) (9) .
Herein, we carried out a genome-wide analysis in a family-based series consisting of young non-smoker lung cancer cases and their unaffected sibs as controls in order to avoid the problem of population stratification. Our findings suggest that lung cancer risk in nonsmokers has an inherited susceptibility component that may override the strong role of the smoking habit (10) . A few loci associated with lung cancer risk in non-smokers were also confirmed in an independent population-based series.
Subjects and methods

Series and DNA pool construction
The family-based case-control series consisted of 80 Italian lung cancer patients and their healthy sibs recruited with the help of Associazione Marta Nurizzo, Brugherio, Italy (http://www.martalive.org/foreign.htm), on a voluntary basis, with recruitment criteria consisting in the non-smoking status and young age (,60 years) of lung cancer cases, although 14 cases were .60 years and 5 cases were ex-smokers (Table I ).
The population-based case-control series consisted of pathologically documented lung adenocarcinoma (ADCA) patients and unrelated healthy individuals enrolled at Istituto Nazionale Tumori (Milan, Italy) from 1980 to 2007. Controls were recruited among blood donors or subjects participating in a computed tomography screening for lung cancer prevention (11) (Table I) . Study protocols were approved by the institute ethics committee and written informed consent was obtained from each subject for the use of his/her biological material.
Genomic DNA was extracted from peripheral blood by standard methods and quantified using Picogreen dsDNA Quantitation Kit (Invitrogen, Carlsbad, CA). DNA of 80 discordant sibships was used to generate two pools (cases or controls) containing 30 ng of each DNA sample.
Single-nucleotide polymorphism markers and genotyping Genome-wide genotyping was carried out in DNA pools prepared from cases and controls of the family-based series. DNA (200 ng per sample) was hybridized using the Infinium II Assay Human610-Quad BeadChip on the Sentrix BeadChip platform (Illumina, San Diego, CA), which allows analysis of 620 901 genetic markers chosen from the International HapMap release 23. For each DNA pool, single-nucleotide polymorphism (SNP) array analysis was carried out in quadruplicate to verify genotype reproducibility and to estimate technical variability. Data were obtained as intensity signals, which were used to determine the allele frequencies of each SNP and to reconstruct the number of chromosomes carrying each of the two possible alleles.
Individual samples were genotyped using MassARRAY (Sequenom, San Diego, CA). Multiplex polymerase chain reaction assays were designed using Sequenom SpectroDESIGNER software by entering the sequence containing the SNP site and 100 bp of flanking sequence on either side of the SNP. SNPs were grouped into multiplexes according to the mass of the extension product over the SNP site. Polymerase chain reaction was carried out in 384-well reaction plates in a volume of 5 ll using 2.5 ng genomic DNA. The extension products were spotted onto a 384-well spectroCHIP before analysis by MAL-DI-TOF mass spectrometry.
Statistical analysis
Differences between lung cancer cases and their sib controls in allelic frequencies assessed in SNP array hybridization were analyzed using random variance t-statistics (12) and BRB ArrayTools (http://linus.nci.nih.gov/BRBArrayTools.html). Differences in chromosome counts between cases and controls were tested by Fisher's exact test or by chi-square analysis when the normal approximation was appropriate. The correlation of the allelic frequencies between SNP array and individual genotypes was expressed as a Pearson's coefficient. Association analyses were carried out using PLINK software (13) , which included analysis of Hardy-Weinberg equilibrium, family-based transmission disequilibrium test (14) and population-based association analyses between disease status and genotype/allelotype. A generalized linear model with binomial errors was used to test the relationship between genetic susceptibility score and proportion of lung cancer cases; the mean values of genetic susceptibility scores were also analyzed using the Kruskal-Wallis test. The age was downcoded to binary dummy variables (age in decades), which were used as covariates in logistic analyses. Linkage disequilibrium between SNP markers was evaluated using JLIN program (15) .
Results
The family-based series points to multiple SNPs associated with lung cancer risk The genome-wide SNP array analysis conducted in quadruplicate on DNA pools of either 80 lung cancer cases or matched healthy sib controls allowed the screening of 620 901 SNPs, with data obtained as intensity signals for each of the two SNP alleles. Analysis of allelic frequencies of each SNP from case and control DNA pools, deleting SNPs whose minor allele frequency in both cases and controls was ,0.1, revealed 659 SNPs with parametric P-values 1.0 Â 10 À7 (equivalent at a false discovery rate P 5 0.0008). For these 659 SNPs, we estimated the number of chromosomes in cases and controls using a Correlation analysis of the minor allele frequencies estimated in cases and controls either in DNA pools by SNP array analysis or in individual samples by MassARRAY for the 75 SNPs associated with lung cancer demonstrated the reliability of the pooling approach (r 5 0.78, P , 2.2 Â 10 À16 , Figure 1) .
Single-point analysis using the sib transmission disequilibrium test indicated that 36 of the 75 genotyped SNPs were significantly associated with disease status (Table II) . The strongest associations were observed for SNPs rs11833102 mapping in the carboxypeptidase M (CPM) gene on chromosomes 12, rs17120323 in the sarcoglycan zeta (SGCZ) gene on chromosome 8, rs12445758 within cadherin 13, H-cadherin (heart) (CDH13) gene on chromosome 16 and rs325702 mapping in the cyclic nucleotide-gated channel alpha 4 (CNGA4) gene on chromosome 11.
The 36 SNPs that were statistically associated with lung cancer in the discordant sibships analysis were replicated in a population-based lung ADCA case-control series. None of them showed significant deviation from the Hardy-Weinberg equilibrium, except for rs11074274 (P 5 0.005, in cases only). Logistic analysis adjusted for sex, age and smoking habit indicated that three SNPs (rs1261411, rs4330610 and rs3019885) were significantly associated in the population-based series (P , 0.05) ( Table III) . Comparison of the cases with early tumor onset (age up to 60 years; n 5 198) versus the whole controls confirmed the association of the SNP rs3019885 on chromosome 8 (P 5 0.029) and detected the association of the SNP rs16937762 on chromosome 9 (P 5 0.024).
The polygenic model of additive and interchangeable effects of the rare alleles explains lung cancer risk in discordant sibships In the family-based series, we tested our recently proposed polygenic model, characterized by additive and interchangeable effects of the rare alleles (6), for the interpretation of individual risk of lung cancer. 
Polygenic risk of lung cancer
Analysis included a total of 35 SNPs, reflecting the exclusion of SNP rs17160175 due to its high linkage disequilibrium with rs11773530 (D# 5 1.0, r 2 5 0.97), and 151 subjects, with five controls and four cases removed from the dataset because .80% genotypes were missing. To test the model, a score of þ1 or À1 was attributed to the rare allele of each SNP based on its association with increased or decreased lung cancer risk, respectively. For each subject, the sum of the scores for all 35 SNPs was obtained as a general estimator of the individual genetic risk. The average estimator was À1.6 ± 0.3 (mean ± standard error) in controls and 2.0 ± 0.3 in cases, respectively (P 5 2.0 Â 10 À11 , Kruskal-Wallis test), and the proportion of lung cancer cases increased at higher genetic susceptibility scores (Figure 2 ; P 5 5.9 Â 10 À9 ).
Applying the same polygenic model in the population-based series, by using the three confirmed SNPs (Table III) , we found that the average estimator was 1.25 ± 0.03 in controls and 1.40 ± 0.03 in cases, respectively (P 5 0.0019, Kruskal-Wallis test).
Discussion
Our use of a sibling-based study design detected loci statistically associated with lung cancer risk, even with a limited number of subjects. Notwithstanding the poor feasibility of the recruitment of healthy sibs controls to carry out family-based genome-wide association studies in lung cancer, due to late age at cancer onset for most of the cases, the possible benefits resulting from the appropriate matching of cases and controls may justify the effort.
An important advantage of the discordant sibs design is the possibility to exclude the potential for bias due to population stratification, which is common in population-based studies (14) . Indeed, cases and controls derive from the same pedigree whose DNA differences may lie in genetic polymorphisms putatively responsible for the disease status. The effect (lung cancer risk estimation) detected by the discordant sib pair design (1:1 case:control ratio) and sib transmission disequilibrium test is due to the combined presence of linkage and association (14) .
Starting from a genome-wide association studies of DNA pools, we identified 36 SNPs that showed significant linkage/association in the family-based series (Table I) . Individual genotyping confirmed the robustness of our pooling approach (Figure 1 ), demonstrating that this method produces reliable results and is time-and cost-effective. Of these 36 genetic markers, 13 mapped within genes. The most significantly associated SNPs (P 0.0045), i.e. rs11833102, rs17120323, rs12445758 and rs325702, mapped in carboxypeptidase M (CPM), sarcoglycan zeta (SGCZ), cadherin 13, H-cadherin (heart) (CDH13) and cyclic nucleotide-gated channel alpha 4 (CNGA4) genes, respectively. Overexpression of CPM was recently reported to correlate negatively with disease survival in human lung ADCA patients (16) , and aberrant methylation of the CDH13 gene was observed in lung ADCA (17) . Thus, our findings point to the relevance of genetic components in the modulation of individual lung cancer risk in non-smokers.
Interestingly, we found that one of the associated SNPs (rs12663498, P 5 0.055) maps on 6q25.1, the same locus previously linked to lung cancer risk in pedigrees with multiple lung cancer members (4) . The SNP maps within the pleckstrin homology domaincontaining family G (with RhoGef domain) member 1 (PLEKHG1) gene, which lies 2 Mb from RGS17, the major candidate gene for the familial lung cancer susceptibility locus (18) .
Our present findings in non-smokers discordant sib pairs did not confirm the previously reported population-based association of lung cancer risk with the chromosome 15q25 nicotinic receptor locus (7) (8) (9) 11) . These results are supported by our recent meta-analysis showing that this locus is not associated with lung cancer risk in .1000 never-smoker cases and .1800 controls (19) .
Another aspect that we should take into consideration is the role of genetic heterogeneity in the predisposition to cancer. Indeed, independent loci may modulate the risk of sporadic and of familial cancer, as the model of breast cancer susceptibility demonstrated (20, 21) . Also, we should consider the great impact of the major environmental risk factor, i.e. smoking habit, and the difficulty in separating the genetic and environmental contributions to lung cancer risk. Indeed, a study in monozygotic and dizygotic twins showed that the possible sharing of the same environmental risk factors may play a major role in lung cancer risk (22) .
The application of the previously proposed polygenic model of interchangeable and additive effects of rare alleles (6) to the 35 SNPs associated in the discordant sib-based series showed a highly statistically significant association between the genetic susceptibility score and the proportion of cancer cases (Figure 2 ), supporting the plausibility of this type of polygenic model.
Our single-point analysis confirmed in the population-based series only 3 of 36 SNPs that were statistically associated in the Logistic regression procedure in PLINK toolset, adjusted for sex, age in decades and smoking habit; P-values obtained by allelic test for association.
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family-based series (Tables II and III) . Since the results of the familybased series are not biased by population structure and most of the detected SNPs presumably represent real associations, the scarce effects of the same SNPs in the population-based series rest in either the existence of significant population admixture, masking real associations, or the existence of phenocopies and a high degree of genetic heterogeneity in the general population. In the latter case, a model of 'private' genetic epidemiology (23) may account for the genetic effects detected in lung cancer families.
Funding
Associazione and Fondazione Italiana Ricerca Cancro; Fondo Investimenti Ricerca di Base, Italy; CEGEN (Spanish National Genotyping Centre), Centro Nacional de Investigaciones Oncologicas Node, Spain.
